Mounjaro is a dual GIP and GLP-1 receptor agonist used to improve blood glucose control in type 2 diabetes, whilst escitalopram is a selective serotonin reuptake inhibitor (SSRI) prescribed for depression and generalised anxiety disorder
[DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted] 170.Xiong X.-H., Zhao Y., Ge X., Yuan S.-J., Wang J.-H., Zhi J.-J., Yang Y.-X., Du B.-H., Guo W.-J., Wang S.-S., et al
Additionally, the proportion of FM/FFM loss was 3.5 in mixed cohorts and 3.9 in female-only groups, suggesting a higher FFM loss in mixed cohort than in female groups
If you are already on metformin and interested in more effective weight loss, PlexusDx providers can evaluate whether adding semaglutide injection or another GLP-1 therapy aligns with your health goals and medical history